The state of Vermont currently has 3 active clinical trials seeking participants for Asthma research studies. These trials are conducted in various cities, including Burlington, Bennington, Berlin and White River Junction.
Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS)
NCT04609878
Recruiting
This is a variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma inadequately controlled with standard of care
Gender:
All
Ages:
Between 12 years and 80 years
Trial Updated:
03/29/2024
Locations: Research Site, Burlington, Vermont
Conditions: Asthma
Register for Updates
Increased Lung Volume as Controller Therapy for Asthma
NCT02953431
Recruiting
This is an early phase clinical trial to test the efficacy of elevating lung volume with positive expiratory pressure (CPAP) as a controller therapy for asthma in patients with a BMI ≥ 30 kg/m2. There will be two phases to this trial. Phase I: In the first phase we will determine the optimal duration of CPAP that is effective as a controller therapy in asthma. Up to 9 participants will complete this this phase. Phase II: The 2nd phase will be a randomized double-blinded controlled trial of... Read More
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
03/17/2023
Locations: Vermont Lung Center, Colchester, Vermont
Conditions: Asthma
Register for Updates
MitoQ for the Treatment of Metabolic Dysfunction in Asthma
NCT04026711
Recruiting
A 14-week, randomized, placebo-controlled, double-masked clinical trial in 40 obese patients with poorly controlled asthma. The intervention is Mitoquinol (MitoQ) versus placebo. The primary aim of this pilot study is to determine if MitoQ improves airway reactivity in obese patients with asthma.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/26/2023
Locations: University of Vermont, Burlington, Vermont
Conditions: Asthma, Obesity
Register for Updates